Management of thyroid cancers

Thyroid cancers cover a large spectrum of disease with diametrically opposite prognosis. At one end of the spectrum we have the well differentiated cancers which carry an excellent prognosis, while at the other end there is anaplastic cancer with high mortality rates and dismal prognosis. Management...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of surgical oncology Vol. 1; no. 2; pp. 151 - 162
Main Authors Chaukar, Devendra A., Deshmukh, Anuja D., Dandekar, Mitali R.
Format Journal Article
LanguageEnglish
Published India Springer-Verlag 01.04.2010
Subjects
Medicine
Medicine & Public Health
Oncology
Review
Review Article
Surgery
Surgical Oncology
Thyroglobulin
Thyroid cancer
Radioiodine treatment
Online AccessGet full text

Cover

More Information
Summary:Thyroid cancers cover a large spectrum of disease with diametrically opposite prognosis. At one end of the spectrum we have the well differentiated cancers which carry an excellent prognosis, while at the other end there is anaplastic cancer with high mortality rates and dismal prognosis. Management of thyroid cancers still has some controversial issues due to lack of randomized controlled trials. Extent of surgery, extent of neck dissection, role of radioiodine treatment and thyroid stimulating hormone suppression are still debatable. In this review, we highlight these controversial issues and give guidelines for the management and follow up of patients with thyroid cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0975-7651
0976-6952
DOI:10.1007/s13193-010-0029-3